Project Grant RF1NS142331
Award Date
5/1/25
Completion Date
4/30/28
Dollars Obligated
$2.7M
Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The National Institute on Aging awarded a $1,931,965 Project Grant (CFDA 93.866 - Aging Research) to the Regenerative Research Foundation to develop and validate a novel 3D human cell model that incorporates cerebral cortical neurons, glia, vascular endothelial cells, pericytes, and microglia derived from induced pluripotent stem cells (iPSCs). The goal is to create an improved model for studying the cerebrovascular interactions underlying Alzheimer's disease-related dementias (ADRD), as current...
The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded Neucyte Inc. a $500,000 Project Grant to develop a nanoluciferase-based microphysiological systems platform for high-throughput screening of potential Alzheimer's disease (AD) and AD-related dementia (ADRD) therapeutics. The project aims to create a scalable, reproducible "mini-brain" assembled organoid (assembloid) model using AD patient-derived and gene-edited induced...
This Project Grant award is funded by the National Institute on Aging (NIA) under the Aging Research Federal Grant Program (CFDA 93.866). The $2,319,456 award will support the University of California, San Diego in developing brain organoid models and leveraging multiomics techniques to investigate the mechanisms underlying Alzheimer's disease (AD) onset and progression. The key products and services to be delivered include: Derivation of 6 isogenic mutant and 3 mutant-corrected human induced...
This is a Project Grant award from the National Institute on Aging (NIA) under the Aging Research Program (CFDA 93.866) in the amount of $2,173,794.00 over the period of Sep 1, 2024 to Aug 31, 2027. The award supports research to explore the mechanisms by which adult hippocampal neurogenesis (AHN) and brain-derived neurotrophic factor (BDNF) cooperate to provide resilience against Alzheimer's disease (AD) pathology and cognitive decline. The research aims to identify novel therapeutic strategies...
This Project Grant award, titled "AHEAD OF THE CURVE: EARLY DETECTION AND MONITORING OF LEARNING DECREMENTS IN ALZHEIMERS DISEASE", is funded by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866). The $2,494,096 award to Brigham & Women's Hospital Inc., a Harvard-affiliated academic medical center, will develop and test a web-based cognitive assessment platform to detect early signs of cognitive decline associated with Alzheimer's disease. The...
This $1,611,000 federal Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to Brigham & Women's Hospital Inc. aims to illuminate the role of somatic mutations in the development of primary tauopathies, a group of neurodegenerative diseases including Alzheimer's. The project will leverage single-cell whole-genome sequencing of human brain tissue to examine somatic mutations in neurons and glia, as well as utilize cellular models to dissect mechanisms...
The National Institute on Aging awarded a $885,006 Project Grant under the Aging Research program (CFDA 93.866) to Brigham & Women's Hospital Inc. to develop a smartphone-based point-of-care diagnostic system for detecting Alzheimer's disease-related biomarkers in blood plasma. The goal is to create an affordable, user-friendly test that can be used in primary care settings, reducing the need for specialist visits and shortening wait times. The system utilizes microfluidics,...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,858,368 to Brigham & Women's Hospital Inc. to conduct research into the role of the SORL1-retromer biology in the pathogenesis of Alzheimer's disease. The project aims to advance the understanding of the mechanisms underlying Alzheimer's disease, with the ultimate completion date set for August 31, 2027. Brigham & Women's Hospital Inc. is a prominent academic medical center...
This $460,625 Project Grant awarded by the National Institute on Aging under CFDA Program 93.866 (Aging Research) aims to gain a mechanistic understanding of the role of cellular senescence in the pathogenesis of Alzheimer's disease. The grant supports research using human induced pluripotent stem cell-based Alzheimer's disease models to dissect the functional consequences of activating the p53/p21 and p16 senescence pathways in differentiated cortical neurons and cerebral organoids. The goal is...
This Project Grant award, valued at $903,172.00, was issued by the National Institute on Aging under the Aging Research Federal Grant Program (CFDA 93.866). The grant supports a research study examining the role of clonal somatic mutations in microglia and their potential contribution to the development of Alzheimer's disease. The key objectives of the study are to: 1) Identify somatic mutations through re-analysis of existing bulk RNA-sequencing datasets from Alzheimer's disease cohorts,...